批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/07/11 |
SUPPL-68(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/12/04 |
SUPPL-62(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2020/12/04 |
SUPPL-60(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2020/09/09 |
SUPPL-57(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/09/09 |
SUPPL-43(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2017/03/16 |
SUPPL-63(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/12/16 |
SUPPL-58(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/02/24 |
SUPPL-40(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2015/01/30 |
SUPPL-53(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/01/23 |
SUPPL-54(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/06/09 |
SUPPL-52(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2013/09/27 |
SUPPL-50(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2013/09/10 |
SUPPL-49(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2013/03/25 |
SUPPL-48(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2011/07/28 |
SUPPL-35(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2010/10/15 |
SUPPL-36(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2005/10/28 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/11/17 |
SUPPL-25(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/05/23 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2002/05/23 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2002/04/26 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2001/06/07 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2000/04/03 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1998/08/12 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1997/01/31 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1996/03/20 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1996/02/01 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1995/11/28 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1995/05/03 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1994/12/01 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1994/12/01 |
SUPPL-3(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1994/02/17 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1992/10/29 |
ORIG-1(原始申请) |
Approval |
Type 5 - New Formulation or New Manufacturer |
PRIORITY
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:MEDROXYPROGESTERONE ACETATE 剂型/给药途径:INJECTABLE;INJECTION 规格:150MG/ML 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020246 |
001 |
NDA |
DEPO-PROVERA |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Prescription |
Yes |
Yes |
AB |
1992/10/29
|
PFIZER |
076553 |
001 |
ANDA |
MEDROXYPROGESTERONE ACETATE |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Prescription |
No |
No |
AB |
2004/07/28
|
HONG KONG |
077235 |
001 |
ANDA |
MEDROXYPROGESTERONE ACETATE |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Prescription |
No |
No |
AB |
2017/11/28
|
AMPHASTAR PHARMS INC |
077334 |
001 |
ANDA |
MEDROXYPROGESTERONE ACETATE |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Prescription |
No |
No |
AB |
2017/11/28
|
AMPHASTAR PHARMS INC |
210227 |
001 |
ANDA |
MEDROXYPROGESTERONE ACETATE |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Prescription |
No |
No |
AB |
2018/10/12
|
XIROMED |
210761 |
001 |
ANDA |
MEDROXYPROGESTERONE ACETATE |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Discontinued |
No |
No |
AB |
2019/04/24
|
SUN PHARM |
210760 |
001 |
ANDA |
MEDROXYPROGESTERONE ACETATE |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Discontinued |
No |
No |
AB |
2019/05/01
|
SUN PHARM |
212824 |
001 |
ANDA |
MEDROXYPROGESTERONE ACETATE |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Prescription |
No |
No |
AB |
2022/08/22
|
EUGIA PHARMA |
212844 |
001 |
ANDA |
MEDROXYPROGESTERONE ACETATE |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Prescription |
No |
No |
AB |
2022/08/31
|
EUGIA PHARMA |
214309 |
001 |
ANDA |
MEDROXYPROGESTERONE ACETATE |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Discontinued |
No |
No |
AB |
2023/01/05
|
HIKMA |
215397 |
001 |
ANDA |
MEDROXYPROGESTERONE ACETATE |
MEDROXYPROGESTERONE ACETATE |
INJECTABLE;INJECTION |
150MG/ML |
Prescription |
No |
No |
AB |
2023/06/07
|
AMNEAL |